The feasibility of (18)F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with (18)F-FDG

PURPOSE: Radiolabeled arginine-glycine-aspartic acid (RGD) peptides have been developed for PET imaging of integrin avβ3 in the tumor vasculature, leading to great potential for noninvasively evaluating tumor angiogenesis and monitoring antiangiogenic treatment. The aim of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yanfen, Liu, Huanhuan, Liang, Sheng, Zhang, Caiyuan, Cheng, Weiwei, Hai, Wangxi, Yin, Bing, Wang, Dengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053646/
https://www.ncbi.nlm.nih.gov/pubmed/27029065
http://dx.doi.org/10.18632/oncotarget.8402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053646/
https://www.ncbi.nlm.nih.gov/pubmed/27029065
http://dx.doi.org/10.18632/oncotarget.8402

Ejemplares similares